1-萘乙酸,a-己基- | 15640-65-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 1-萘乙酸,a-己基-
• 英文名称: α-Hexyl-(1-naphthyl)-essigsaeure
• 英文别名: 2-[1]naphthyl-octanoic acid；2-[1]Naphthyl-octansaeure；2-Naphthalen-1-yloctanoic acid
• CAS: 15640-65-0
• 化学式: C₁₈H₂₂O₂
• 分子量: 270.371
• InChiKey: HKRWBQFICVBDQV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  20
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 生成 1-萘乙酸,a-己基-
  参考文献：
  名称：

  Ukita et al., Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1951, vol. 71, p. 289,291

  摘要：

  DOI：

文献信息

• Manufacture of higher aryl esters
  申请人：Ashland Oil, Inc.

  公开号：EP0163748A1

  公开（公告）日：1985-12-11

  The oxidation process for the manufacture of higher aryl esters comprising contacting the reaction mixture of a higher aromatic hydrocarbon, an organic solvent, a carboxylic acid and molecular oxygen in the liquid phase at an elevated temperature with a catalyst composed of palladium or a compound of palladium, an antimony compound and a compound of at least one member selected from the group consisting of alkali metals and alkaline earth metals is described.

  本发明描述了制造高级芳基酯的氧化工艺，该工艺包括在高温下将液相中的高级芳香烃、有机溶剂、羧酸和分子氧的反应混合物与由钯或钯、锑化合物和至少一种选自碱金属和碱土金属的化合物组成的催化剂接触。
• Strains of bacillus thuringiensis
  申请人：PLANT GENETIC SYSTEMS, N.V.

  公开号：EP0382990A1

  公开（公告）日：1990-08-22

  Two new Bacillus thuringiensis strains, which are deposited at the DSM under accession nos. 5131 and 5132, produce crystal proteins during sporulation that are toxic to Coleoptera. The crystal proteins contain 74 kDa and 129 kDa protoxins, respectively, which can yield 67 and 66 kDa toxins, respectively, as trypsin-digestion products. A plant, the genome of which is transformed with a DNA sequence that comes from either one of the strains and that codes for its respective toxin, is resistant to Coleoptera. Each strain, itself, or its crystals, crystal proteins, protoxin or toxin can be used as the active ingredient in an insecticidal composition for combatting Coleoptera.

  两种新的苏云金芽孢杆菌菌株（存于 DSM，登录号分别为 5131 和 5132）在孢子化过程中会产生对鞘翅目昆虫有毒的晶体蛋白。晶体蛋白分别含有 74 kDa 和 129 kDa 的原毒素，作为胰蛋白酶消化产物，可分别产生 67 kDa 和 66 kDa 的毒素。植物的基因组经 DNA 序列转化后，对鞘翅目昆虫具有抗性。每种菌株本身或其晶体、晶体蛋白、原毒素或毒素都可用作防治鞘翅目昆虫的杀虫组合物的活性成分。
• Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same
  申请人：YEDA RESEARCH AND DEVELOPMENT CO., LTD.

  公开号：EP2319857A2

  公开（公告）日：2011-05-11

  The present invention concerns an isolated polynucleotide comprising a nucleic acid sequence encoding a mutated PON enzyme exhibiting an increased substrate specificity to at least one known PON substrate as compared to a respective wild-type PON.

  本发明涉及一种分离的多核苷酸，该多核苷酸包含编码变异 PON 酶的核酸序列，与各自的野生型 PON 相比，变异 PON 酶对至少一种已知 PON 底物具有更强的底物特异性。
• NOVEL STRAIN HAVING PROPHYLACTIC OR THERAPEUTIC EFFECT ON CANCER
  申请人：Genome and Company

  公开号：EP3792343A1

  公开（公告）日：2021-03-17

  The present invention relates to a novel Bifidobacterium bifidum MG731 strain and a composition for preventing or treating cancers, comprising the same. Specifically, the Bifidobacterium bifidum MG731 strain of the present invention has effects of inhibiting the proliferation of cancer cells, decreasing the mobility of cancer cells, inhibiting the neoangiogenesis, and increasing the anticancer immune response as well as reducing the expression of inflammatory factors, thereby having effects of preventing or treating cancers or inflammatory diseases. In addition, when used in combination with an anticancer chemotherapeutic agent or an anticancer immunotherapeutic agent, the Bifidobacterium bifidum MG731 strain of the present invention exhibits a better anticancer effect. In addition, the present invention relates to a novel Lactococcus lactis GEN3033 strain and a composition for preventing or treating cancers, comprising the same. Specifically, the Lactococcus lactis GEN3033 strain of the present invention exhibits effects of directly inhibiting the proliferation of cancer cells and enhancing immunity, thereby having effects of preventing or treating cancers. In particular, the strain has an excellent anticancer effect by secreting metabolites having an anticancer effect while being established in the gut. In addition, when used in combination with an anticancer chemotherapeutic agent or an anticancer immunotherapeutic agent, the Lactococcus lactis GEN3033 strain of the present invention exhibits a better anticancer effect.

  本发明涉及一种新型双歧杆菌 MG731 菌株和一种预防或治疗癌症的组合物。具体来说，本发明的双歧杆菌 MG731 菌株具有抑制癌细胞增殖、降低癌细胞流动性、抑制新血管生成、增加抗癌免疫反应以及减少炎症因子表达的作用，从而具有预防或治疗癌症或炎症性疾病的效果。此外，本发明的双歧杆菌 MG731 菌株与抗癌化疗药物或抗癌免疫治疗药物联合使用时，抗癌效果更好。此外，本发明还涉及一种新型乳球菌 GEN3033 菌株和一种预防或治疗癌症的组合物。具体而言，本发明的乳球菌 GEN3033 菌株具有直接抑制癌细胞增殖和增强免疫力的作用，从而具有预防或治疗癌症的效果。特别是，该菌株在肠道中生长时，通过分泌具有抗癌作用的代谢物，具有极佳的抗癌效果。此外，当与抗癌化疗剂或抗癌免疫治疗剂联合使用时，本发明的乳球菌 GEN3033 菌株表现出更好的抗癌效果。
• Biological indicator
  申请人：American Sterilizer Company

  公开号：US10011843B2

  公开（公告）日：2018-07-03

  This invention relates to a biological indicator derived from a composition comprising: a host organism comprising a spore forming bacteria; a reporter gene for producing an indicator enzyme; a regulatory gene; and a vehicle for inserting the reporter gene and the regulatory gene in the host organism; the host organism bearing a transposable genetic element in its genome for inserting an insertion sequence in the regulatory gene; the insertion sequence comprising a transposase, a pair of terminal inverted repeat sequences, and at least one open reading frame for expressing the transposase. The vehicle may be taken up by the host organism. The insertion sequence may be inserted in the regulatory gene. The host organism may undergo sporulation to form the biological indicator. A process and an apparatus for using the biological indicator are disclosed.

  本发明涉及一种生物指示剂，其成分包括：由形成孢子的细菌组成的宿主生物；产生指示剂酶的报告基因；调控基因；以及将报告基因和调控基因插入宿主生物的载体；宿主生物的基因组中含有转座遗传因子，用于在调控基因中插入插入序列；插入序列包括转座酶、一对末端倒置重复序列和至少一个用于表达转座酶的开放阅读框。载体可被宿主生物吸收。插入序列可插入调控基因中。宿主生物可进行孢子繁殖以形成生物指示剂。本发明公开了一种使用生物指示剂的工艺和装置。